ArticleSensors (Basel, Switzerland)2024
Diagnosis of Pancreatic Ductal Adenocarcinoma Using Deep Learning.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- From radiomics to transformers in pancreatic cancer detection and prognosis.Frontiers in medicine · 2025Pooled it
- Explainable Lightweight Model Using Low-Rank and Convolutional Block Attention for Pancreatic Cancer Diagnosis.The international journal of medical robotics + computer assisted surgery : MRCAS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in artificial intelligence (AI) research, particularly in image processing technologies, have shown promising applications across various domains, including health care. There is a significant effort to use AI for the early diagnosis and detection of diseases, offering cost-effective and timely solutions to enhance patient outcomes. This study introduces a deep learning network aimed at analyzing pathology images for the accurate diagnosis of pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC). Utilizing a novel dataset comprised of cases diagnosed with PDAC and/or chronic pancreatitis, this study applies deep learning algorithms to assess the effectiveness and reliability of the diagnostic process. The dataset was enhanced through image duplication and the creation of a second dataset with varied dimensions, facilitating the training of advanced transfer learning models including InceptionV3, DenseNet, ResNet, VGG, EfficientNet, and a specially designed deep neural network. The study presents a convolutional neural network model, optimized for the rapid and accurate detection of pancreatic cancer, and conducts a comparative analysis with other models to select the most accurate algorithm for a decision support system. The results from Dataset 1 show that EfficientNetB0 achieved a high success rate of 92%. In Dataset 2, VGG16 was found to have high performance, with a success rate of 92%. On the other hand, ResNet50 achieved a remarkable success rate of 96% despite a moderate training time and showed high precision, recall, F1 score, and accuracy. These results provide valuable data to demonstrate and share the relevance of different deep learning models in pancreatic cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.